Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05791240 · ClinicalTrials.gov registry record · NA
Family-Initiated Interpretation in the PICU
A NA study of Limited English Proficiency, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 292
- Enrollment target
- 1
- Study location
NCT05791240: Completed NA study of Limited English Proficiency, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
NCT05791240 is a NA study of Limited English Proficiency that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 292 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05791240, a NA study of Limited English Proficiency, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 292 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to compare interpreter use rates before and after allowing non-English speaking families to call an interpreter themselves. The main questions it aims to answer are: Is it feasible for families to call an interpreter themselves? Will allowing families to call an interpreter themselves increase the rate of professional interpreter utilization? Participants will be given an interpreting tablet and instructed to use the interpreter application whenever they would like to talk to the medical team. There will be a short survey on the feasibility and acceptability of the intervention for the patients and the medical team. The study team will then look at interpreter use rates before and after the intervention.
Primary Outcome
Number of interpreter encounters per limited English proficiency patient day
Conditions Studied
Interventions
- BEHAVIORAL Family Initiated Interpretation
Study Locations (1)
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 292 participants |
| Start Date | 2023-04-03 |
| Est. Completion | 2024-04-01 |
| Phase | NA |
What the finished NCT05791240 record still lists
NCT05791240 is an interventional study that assigns participants to a tested intervention. The registered 292 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Limited English Proficiency appearing as the primary indexed condition, and to 1 intervention - of which Family Initiated Interpretation is the first listed.
NCT05791240 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05791240 about?
NCT05791240 is a clinical study titled "Family-Initiated Interpretation in the PICU". The goal of this study is to compare interpreter use rates before and after allowing non-English speaking families to call an interpreter themselves. The main questions it aims to answer are: Is it feasible for families to call an interpreter themselves? Will allowing families to call an interprete...
What is the current status of trial NCT05791240?
This trial is currently completed. It is a NA study. The enrollment target is 292 participants. The study started on 2023-04-03. Estimated completion is 2024-04-01.
What conditions does trial NCT05791240 study?
This clinical trial studies the following conditions: Limited English Proficiency.
What interventions are being tested in trial NCT05791240?
The interventions under investigation include: Family Initiated Interpretation (BEHAVIORAL).
Who is sponsoring clinical trial NCT05791240?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05791240 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Limited English Proficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05791240's enrollment target sits among peer trials
292 375th of 2000 higher than 1,626 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04429542 · 292 participants · Phase 1
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- NCT05406622 · 292 participants · NA
MOTIV BTK Randomized Controlled Trial
- NCT05757102 · 292 participants · Phase 3
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- NCT06569667 · 292 participants · NA
Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI